Findings revealed that soluble CX3CL1 signalling does not influence fibrillar Aβ deposition and tau phosphorylation, while the membrane-bound isoform reduces Aβ and increases tau phosphorylation, being responsible for AD hallmark-related changes in CX3CL1 deficient mice. The gene discussed is MAPT; the disease is Alzheimer disease.